📰 Notable Labs News
Page 2 - Notable Labs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Notable Labs. Real-time updates on events, politics, business and more.
November 22, 2023
Notable Labs, Ltd. (NASDAQ:NTBL – Free Report) – Analysts at Chardan Capital issued their FY2024 earnings estimates for shares of Notable Labs in a research report issued on Monday, November 20th. Chardan Capital analyst K. Nakae expects that the company will earn ($1.21) per share for the year. Chardan Capital has a “Buy” rating on […]
November 15, 2023
MODI`IN , Israel (AP) — MODI`IN, Israel (AP) — Notable Labs, Ltd. (NTBL) on Tuesday reported a loss of $1.1 million in its third quarter.
October 18, 2023
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Building Permits, Housing Starts; 12:00ET Fed’s Waller speaks; 12:30ET Fed’s Williams speaks; 1:00ET Fed’s Bowman and Barkin speak; 2:00ET Fed’s Beige Book; 3:15ET Fed’s Harker speaks TODAY’S HIGHLIGHTS: Biden’s summit with Arab leaders was cancelledBiden says hospital blast in Gaza 'appears
October 18, 2023
Gainers Biocept, Inc. (NASDAQ:BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed...
October 18, 2023
Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.
October 17, 2023
NTBL | Complete Notable Labs Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
October 17, 2023
By Denny Jacob Notable Labs shares declined 31% to $3.75 following its completed merger with VBL Therapeutics. The stock is on pace for a new all-time low...
August 29, 2023
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
August 28, 2023
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of Vascular Biogenics Ltd. operating as VBL...
August 14, 2023
Merger with Notable expected to close in late September or October, subject to VBL’s S-4 registration statement being declared effective and shareholder approval $24.3 million in cash and cash equivalents as of June 30, 2023 MODI’IN, Israel and NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced financial results for the second quarter ended June 30, 2023, and provided a corporate update. “We continue to make goo...